Effects of Heparin on Inflammatory Factor and Tissue Factor Pathway Inhibitor in Patients with Kawasaki Disease

SHI Hong,LI Xiao-jing,ZHANG Qing,ZHOU Min,XU Ming,LI Dan,LI Hui,WANG Xue-mei,HUANG Cheng,LI Xiao-hui

DOI: https://doi.org/10.3969/j.issn.1009-6213.2012.03.008

2012-01-01

Abstract:Objective To study the levels of serous IL-6,TNF-α and TFPI in different treatment for patient with Kawasaki disease(KD).And to investigate the mechanism of heparin in KD. Methods 56 patients with KD and twenty healthy children as control were recruited into the study.The patients with KD were randomly divided into two groups: heparin treatment group and conventional treatment group.The plasma IL-6,TNF-α and TFPI levels were detected by ELISE Methods. Results The levels of plasma IL-6,TNF-α were significantly increased in patients with KD before treatment compared with the healthy control group.After treatment for five to seven days,two to 3 weeks and 2~3 months,IL-6,TNF-α levels were significantly decreased,while TFPI levels was significantly increased.After treatment for 5~7 days,the levels of plasma IL-6,TNF-α were significantly decreased in the heparin treatment group than those in the conventional treatment group(8.059±3.658 pg/ml vs 17.218±10.215 pg/ml,33.72±18.34 pg/ml vs 67.85±32.78 pg/ml,P<0.05),the level of TFPI was significantly increased in the heparin treatment group than that in the conventional treatment group(50.367±10.246 pg/ml vs 43.787±7.0594 pg/ml,P<0.05).Which can last two to three months(41.048±6.215 pg/ml vs 29.885±7.259 pg/ml),the different is statistic significant.(P<0.05). Conclusion The plasma levels of IL-6,TNF-α and TFPI advance at acute phase in KD,and TFPI lasts a quite long time.Heparin could decrease the plasma levels of IL-6,TNF-α by increasing TFPI to educe dual effects of anti-inflammatory and anticoagulation,eventually,diminished the damage of immune vasculitis and reduce the hypercoagulability in KD.